Propranolol Reduces Infantile Hemangioma Volume and Vessel Density

Abstract

Objective To evaluate changes in infantile hemangioma tissue before and after propranolol therapy, using gray-scale and color Doppler ultrasound imaging. Study Design Case series with chart review. Setting Tertiary pediatric hospital. Subjects and Methods Medical records and image studies of head and neck infantile hemangioma patients treated with propranolol, identified in a quality improvement database, were reviewed. Patients with imaging before and at least 4 weeks following the initiation of treatment were included. Data collected included sex, age, location, and concurrent treatment. Student t tests were used to evaluate change in cutaneous lesion area, volume, and vessel density. Logistic regression was used to compare lesion area, volume, and vessel density. Results Of the 177 patients identified, 19 met inclusion criteria. Fourteen of 19 were female, and 5 of 19 were older than 1 year. Mean lesion area change with treatment was 13.0 cm2 (range, −2.8 to 28.9 cm2, P = .05). Measured volume change was a mean of 10.3 cm3 (range, 1.5-19.2 cm3, P = .01). Mean vessel density change was 4.4 vessels per cm2 (range, 2.5-6.3 vessels per cm2, P < .01). Treatment decreased clinically determined hemangioma area proportionately less than gray-scale and color Doppler ultrasound measured lesion volume. Gray-scale and color Doppler ultrasound measured treatment response did not differ with sex, lesion location, or age at propranolol initiation. Conclusion Gray-scale and color Doppler ultrasound imaging of propranolol-treated infantile hemangiomas detected a significant reduction in lesion volume and vessel density. Patient age at propranolol treatment and concomitant corticosteroid use did not affect lesion volume change.

Propranolol as an Alternative Treatment Option for Pediatric Lymphatic Malformation

“…In LM, gadolinium-enhanced lesions consist of hypervascular or mixed vascular lesions. Therefore, propranolol may have a positive effect on these lesions through blood flow because propranolol treatment reduces lesion volume and vessel density in patients of IH (Bingham et al 2012). Propranolol might be more effective for LMs with gadolinium-enhanced lesions than for those without such lesions.…”

Diagnosis and Management of Infantile Hemangioma

“…Gray scale and color Doppler ultrasonography have also demonstrated utility in monitoring the response of IH to medical therapy. 127 Ultrasonography is also a good first-line modality to screen patients with multifocal IHs for liver or visceral involvement, although MRI is preferable to assess complicated or extensive visceral lesions. 128 The extent of the lesion and the surrounding anatomy are better shown on MRI.…”

73 Management of Vascular Anomalies: Hemangiomas and Malformations

“…However, clinical follow-up is more important than imaging. 23 Children with concern for PHACE syndrome should undergo imaging of the brain with magnetic resonance imaging (MRI) to evaluate for posterior fossa lesions, echocardiogram, and possibly angiography or magnetic resonance angiography to evaluate for aortic and cerebrovascular anomalies. When imaging is desired to determine the extent of the tumor, contrast-enhanced MRI is the modality of choice and provides excellent evaluation of soft tissue without exposing the patient to ionizing radiation.…”